Brian Piekos - 09 Sep 2024 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
09 Sep 2024
Transactions value $
$0
Form type
3
Filing time
11 Sep 2024, 16:32:37 UTC
Previous filing
05 Feb 2024
Next filing
25 Feb 2025

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.